Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target alpha5 integrin in colon cancer cells

Citer cette référence
JANOUSKOVA, H., RAY, A. M., NOULET, Fanny, LELONG-REBEL, Isabelle, CHOULIER, Laurence, SCHAFFNER, F., LEHMANN, Maxime, MARTIN, Sophie, TEISINGER, J. et DONTENWILL, Monique, 2013. Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target alpha5 integrin in colon cancer cells. Cancer Letters [en ligne]. 2013. Vol. 336, n° 2pp. 307-318. [Consultésans date]. DOI 10.1016/j.canlet.2013.03.018. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/23523610